Orgenesis (ORGS)
(Delayed Data from NSDQ)
$0.81 USD
-0.12 (-12.38%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $0.80 -0.01 (-1.83%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Orgenesis Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1 | 36 | 36 | 8 | 33 |
Cost Of Goods | 6 | 27 | 37 | 84 | 18 |
Gross Profit | -6 | 9 | -1 | -76 | 15 |
Selling & Adminstrative & Depr. & Amort Expenses | 48 | 18 | 13 | 19 | 40 |
Income After Depreciation & Amortization | -54 | -9 | -15 | -96 | -25 |
Non-Operating Income | -8 | -1 | -2 | 0 | 0 |
Interest Expense | 3 | 2 | 1 | 1 | 1 |
Pretax Income | -64 | -12 | -18 | -97 | -25 |
Income Taxes | 0 | 0 | 0 | -2 | 1 |
Minority Interest | -10 | 3 | 0 | -1 | 2 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -65 | -12 | -18 | -95 | -26 |
Extras & Discontinued Operations | 0 | 0 | 0 | 96 | 0 |
Net Income (GAAP) | -55 | -15 | -18 | 1 | -28 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -52 | -7 | -13 | -94 | -21 |
Depreciation & Amortization (Cash Flow) | 2 | 2 | 2 | 1 | 4 |
Income After Depreciation & Amortization | -54 | -9 | -15 | -96 | -25 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 29.01 | 25.10 | 24.27 | 21.32 | 15.91 |
Diluted EPS Before Non-Recurring Items | -1.91 | -0.59 | -0.74 | -4.46 | -1.77 |
Diluted Net EPS (GAAP) | -1.91 | -0.59 | 0.74 | 0.29 | -1.77 |
Fiscal Year end for Orgenesis Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.25 | 0.14 | -13.60 | 0.11 | 6.98 |
Cost Of Goods | 2.03 | 2.86 | -0.65 | 0.95 | 3.23 |
Gross Profit | -1.78 | -2.72 | -12.95 | -0.84 | 3.74 |
SG&A, R&D, and Dept/Amort Expenses | 2.47 | 6.21 | 22.40 | 10.91 | 7.08 |
Income After SG&A, R&D, and Dept/Amort Expenses | -4.25 | -8.93 | -35.35 | -11.75 | -3.34 |
Non-Operating Income | -4.30 | -0.21 | -8.44 | 0.00 | 0.41 |
Interest Expense | 0.82 | 0.85 | 0.69 | 0.51 | 0.66 |
Pretax Income | -9.36 | -9.99 | -44.48 | -12.26 | -3.57 |
Income Taxes | 0.01 | 0.02 | -0.14 | 0.39 | 0.09 |
Minority Interest | -0.46 | -0.24 | -9.95 | 0.00 | 0.47 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -9.37 | -10.01 | -44.34 | -12.65 | -3.66 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -8.90 | -9.77 | -34.39 | -12.65 | -4.13 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 38.86 | 33.18 | NA | 29.16 | 28.36 |
Diluted EPS Before Non-Recurring Items | -0.23 | -0.29 | NA | -0.43 | -0.15 |
Diluted Net EPS (GAAP) | -0.23 | -0.29 | -1.17 | -0.43 | -0.15 |